Fructose absorption is limited by the availability and activity of enzymes and transporters sufficient to break down and absorb fructose. FructosAid is the U.S. brand name for Xylose Isomerase (XI), an enzyme that converts dietary fructose in the gut into glucose the body readily absorb and use.
FructosAid is produced under patent by Sciotec Pharma GmbH of Austria, a division of STADA Arzneimittel, and is marketed in the U.S. by 88 Health Products under exclusive license. XI is sold in Europe under the brand name Xylosolv®.
Food allergy and intolerance expert Dr. Janice Joneja, Ph.D., R.D. has endorsed FructosAid and Xylosolv, calling XI "a true blessing for those struggling with the discomfort of Fructose Malabsorption."
Consumers can learn more about FructosAid and purchase directly at www.fructosaid.com. The supplement is also available through Swanson Health Products and on Amazon.com. FructosAid is one of three innovative enzyme supplements for dietary intolerances available from 88 Health Products online at www.88healthproducts.com.
An unsolicited online reviewer for FructosAid on Amazon.com wrote: "I can't believe it—I can eat things again that I haven't been able to eat for years. For me this pill is magic."
88 Health Products exclusively markets physician-formulated, clinically validated nutraceuticals and topical solutions for both established and emerging health concerns that can be effectively addressed through diet, nutrition and natural alternatives.
Press Contact: Kurt D. Cameron │ HACK Marketing LLC │ HACKmktg@gmail.com │ 701.541.1362
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/fructosaid-launches-first-us-enzyme-supplement-for-fructose-malabsorption-300300210.html
SOURCE 88 Health Products